Skip to Main Content (Press Enter)

Logo UNINSUBRIA
  • ×
  • Home
  • Degrees
  • Courses
  • Jobs
  • People
  • Outputs
  • Organizations
  • Third Mission
  • Projects
  • Expertise & Skills

UNI-FIND
Logo UNINSUBRIA

|

UNI-FIND

uninsubria.it
  • ×
  • Home
  • Degrees
  • Courses
  • Jobs
  • People
  • Outputs
  • Organizations
  • Third Mission
  • Projects
  • Expertise & Skills
  1. Outputs

The Role of Selective Drug Therapy in Reducing Mortality in the High-risk Surgical Patients (Tranexamic Acid, Selective Bowel Tract Decontamination, Levosimendan, Beta-blockers, Insulin, Aprotinin, and Statins)

Chapter
Publication Date:
2023
abstract:
Among the numerous drugs which can be used perioperatively, there are few with a documented effect on survival according to randomized trials. Tranexamic acid, selective bowel tract decontamination, and levosimendan were found to increase survival. Beta-blockers, insulin, aprotinin, and statins increase mortality in the perioperative setting. We describe the evidence-based medicine supporting or discouraging the use of these drugs together with the physiopathology and the rationale supporting their use or their investigation. Furthermore, numerous other interventions which have at least one randomized trial to support their effect on perioperative mortality are summarized in a final table.
Iris type:
Capitolo di Libro
Keywords:
Anesthesia; Aprotinin; Beta-blockers; Insulin; Levosimendan; Mortality reduction; Noncardiac surgery; Perioperative; Selective digestive tract decontamination; Statin; Tranexamic acid
List of contributors:
Landoni, G.; Baiardo Redaelli, M.; Zangrillo, A.
Authors of the University:
BAIARDO REDAELLI MARTINA
Handle:
https://irinsubria.uninsubria.it/handle/11383/2186721
Book title:
The High-Risk Surgical Patient
  • Accessibility
  • Use of cookies

Powered by VIVO | Designed by Cineca | 26.9.3.0